グループのクイック参照
-
1
Brand-name or SRA + EU/PIC/S-GMP
-
2
Vietnam + EU/PIC/S-GMP
-
3
Imported WHO-GMP + BE proven
-
4
Vietnam WHO-GMP + BE proven
-
5
WHO-GMP, no BE
Circular 15/2019/TT-BYT (Article 6) — foundational 5-group framework. Currently in force: Circular 40/2025/TT-BYT (effective 25 October 2025), which preserves the same group criteria with refined wording and mid-contract drug-substitution rules.
詳細は 入札ガイドを参照。